Language selection

Government of Canada / Gouvernement du Canada

Search

Role of policosanols in the prevention and treatment of cardiovascular disease

From National Research Council Canada

AuthorSearch for: ; Search for: ; Search for:
FormatText, Article
Abstract
Policosanols are a mixture of aliphatic alcohols derived from purified sugar cane. When administered at 5 to 20 mg/day, policosanols have been shown to decrease the risk of atheroma formation by reducing platelet aggregation, endothelial damage, and foam cell formation in animals. Additionally, policosanols have been shown to lower total and low-density lipoprotein (LDL) cholesterol levels by 13 to 23% and 19 to 31%, respectively, while increasing high-density lipoprotein (HDL) cholesterol from 8 to 29%. Policosanols are thought to improve lipid profiles by reducing hepatic cholesterol biosynthesis while enhancing LDL clearance. When compared with statins, policosanols exhibit comparable cholesterol-lowering effects at much smaller doses. The mixture is well tolerated when administered to animals; however, a more precise safety profile is needed for humans. In summary, policosanols are a promising resource in the prevention and therapy of cardiovascular disease (CVD), but these results need to be confirmed in independent laboratories.
Publication date
PublisherInternational Life Sciences Institute
In
  • Nutrition Reviews 61, no. 11: 376–383.
LanguageEnglish
Peer reviewedYes
NRC publication
This is a non-NRC publication

"Non-NRC publications" are publications authored by NRC employees prior to their employment by NRC.

NPARC number23001742
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier14b41734-5734-4361-8381-8b11cbb77571
Record created2017-03-27
Record modified2020-04-02
Date modified: